grumous - meaning and definition. What is grumous
Diclib.com
ChatGPT AI Dictionary
Enter a word or phrase in any language 👆
Language:

Translation and analysis of words by ChatGPT artificial intelligence

On this page you can get a detailed analysis of a word or phrase, produced by the best artificial intelligence technology to date:

  • how the word is used
  • frequency of use
  • it is used more often in oral or written speech
  • word translation options
  • usage examples (several phrases with translation)
  • etymology

What (who) is grumous - definition

PROCESS IN WHICH THE COAGULATION FACTORS OF THE BLOOD INTERACT, ULTIMATELY RESULTING A CLOT
Blood coagulation; Coagulation factors; Coagulation factor; Blood clotting; Clotting factors; Clotting factor; Common pathway; Clotting; Coagulation system; Coagulate; Blood Clotting; Coagulation of human blood; Coagulation cascade; Blood clotting spray; Blood Clotting Spray; Clotting cascade; Coagulating; Coagulative; Blood coagulation factors; Blood coagulation tests; Blood coagulation factor inhibitors; Blood clotting cascade; Grumous; Secondary hemostasis; Blood-clotting; Blood clotting mechanism; Clot formation; Factor 4; Factor IV; Clotting system; Procoagulant; Platelet activation; Thrombokinesis; Primary hemostasis; Form clots; Tissue factor pathway; Blood clotting factors; Blood clotting factor; Coagulation protein; Coagulation proteins; Bloodclotting; Procoagulation; Proagulatory; Procoagulatory; Pro-coagulatory; Pro-coagulant; Pro-coagulation; Coagulation pathway; Fibrinogenesis; Coagulation activation; Fibrin generation; Fibrin formation; Fibrin genesis; Fibrin production; Fibrin synthesis
  • isbn=978-1-904842-39-2}}</ref>
  • Coagulation with arrows for negative and positive feedback.
  • enzymatic activity]].
  • GPV]] allows for platelets to adhere to the site of injury. Mutations in the genes associated with the glycoprotein Ib-IX-V complex are characteristic of [[Bernard–Soulier syndrome]]
  • Modern coagulation pathway. Hand-drawn composite from similar drawings presented by Professor Dzung Le, MD, PhD, at UCSD Clinical Chemistry conferences on 14 and 21 October 2014. Original schema from Introduction to Hematology by Samuel I. Rapaport. 2nd edition;Lippencott:1987. Dr Le added the factor XI portion based on a paper from about year 2000. Dr. Le's similar drawings presented the development of this cascade over 6 frames, like a comic.
  • The interaction of vWF and GP1b alpha. The GP1b receptor on the surface of platelets allows the platelet to bind to vWF, which is exposed upon damage to vasculature. The vWF A1 domain (yellow) interacts with the extracellular domain of GP1ba (blue).

grumous         
a.
Clotted, concreted, thick.
Grumous         
·adj ·see Grumose.
II. Grumous ·adj Resembling or containing grume; thick; concreted; clotted; as, grumous blood.
Grumousness      
·noun The state of being grumous.

Wikipedia

Coagulation

Coagulation, also known as clotting, is the process by which blood changes from a liquid to a gel, forming a blood clot. It potentially results in hemostasis, the cessation of blood loss from a damaged vessel, followed by repair. The mechanism of coagulation involves activation, adhesion and aggregation of platelets, as well as deposition and maturation of fibrin.

Coagulation begins almost instantly after an injury to the endothelium lining a blood vessel. Exposure of blood to the subendothelial space initiates two processes: changes in platelets, and the exposure of subendothelial tissue factor to plasma factor VII, which ultimately leads to cross-linked fibrin formation. Platelets immediately form a plug at the site of injury; this is called primary hemostasis. Secondary hemostasis occurs simultaneously: additional coagulation (clotting) factors beyond factor VII (listed below) respond in a cascade to form fibrin strands, which strengthen the platelet plug.

Disorders of coagulation are disease states which can result in problems with hemorrhage, bruising, or thrombosis.

Coagulation is highly conserved throughout biology. In all mammals, coagulation involves both cellular components (platelets) and proteinaceous components (here, coagulation factors). The pathway in humans has been the most extensively researched and is the best understood.